Invited commentary.
Flores
Raja M
RM
Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Room C-879, New York, NY 10021, USA. floresr@mskcc.org
D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000009:adverse effects; D002404:Catheterization; D003131:Combined Modality Therapy; D003680:Deglutition Disorders / Q000209:etiology; D004931:Esophageal Achalasia / Q000175:diagnosis / Q000601:surgery*; D049630:Esophageal Sphincter, Lower / Q000601:surgery*; D018662:Fundoplication; D006356:Heartburn / Q000209:etiology; D006801:Humans; D007273:Injections, Intramuscular; D010535:Laparoscopy; D057045:Laryngopharyngeal Reflux / Q000209:etiology; D016017:Odds Ratio; D011183:Postoperative Complications / Q000209:etiology*; D011446:Prospective Studies; D012086:Reoperation
D019274:Botulinum Toxins, Type A